Comparison of tamsulosin vs. tamsulosin plus mirabegron in the management of overactive bladder in men with lower urinary tract symptoms
Phase 4
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2022/09/045280
- Lead Sponsor
- Dr Harmandeep Singh Chahal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
newly diagnosed uncomplicated BPE of any size with predominant OABSS and an IPSS >7 without any medical contraindications to planned drug therapy or any absolute indication for surgery
Exclusion Criteria
history of anaphylaxis/ hypersensitivity, drug therapy with metabolic interference to administered medication, prostatic/urethral surgery and other concomitant prostate disease/ cancers, clinical neurological disorders and or neurogenic bladder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in OABSSTimepoint: Day 0; <br/ ><br>After 8 weeks
- Secondary Outcome Measures
Name Time Method improvement in IPSSTimepoint: Day 0; <br/ ><br>After 8 weeks